These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 18697573)
61. Use of domperidone as a prokinetic and antiemetic. Albright LM Int J Pharm Compd; 2005; 9(2):120-5. PubMed ID: 23924913 [No Abstract] [Full Text] [Related]
62. Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in mice. Suchitra AD; Dkhar SA; Shewade DG; Shashindran CH World J Gastroenterol; 2003 Apr; 9(4):779-83. PubMed ID: 12679931 [TBL] [Abstract][Full Text] [Related]
63. Effect of ATP sensitive potassium channel modifiers on antinociceptive effect of metoclopramide. Reddy PM; Shantanu S; Shewade DG; Ramaswamy S Indian J Exp Biol; 2001 May; 39(5):476-8. PubMed ID: 11510133 [TBL] [Abstract][Full Text] [Related]
64. [Effect of prokinetic agents on the electrical activity of stomach and duodenum in rats]. Li F; Zou Y; Huang T Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 34(7):599-602. PubMed ID: 19648670 [TBL] [Abstract][Full Text] [Related]
65. Quinine-induced inhibition of gastrointestinal transit in mice: possible involvement of endogenous opioids. Santos FA; Rao VS Eur J Pharmacol; 1999 Jan; 364(2-3):193-7. PubMed ID: 9932723 [TBL] [Abstract][Full Text] [Related]
66. Obstructive cholestasis alters intestinal transit in mice: role of opioid system. Ghaffari K; Savadkuhi ST; Honar H; Riazi K; Shafaroodi H; Moezi L; Ebrahimkhani MR; Tahmasebi MS; Dehpour AR Life Sci; 2004 Dec; 76(4):397-406. PubMed ID: 15530502 [TBL] [Abstract][Full Text] [Related]
67. Role of ion channel modifiers in reversal of morphine-induced gastrointestinal inertia by prokinetic agents in mice. Sandhiya S; Dkhar SA; Krishna PR; Ramaswamy S Indian J Exp Biol; 2008 Jan; 46(1):60-5. PubMed ID: 18697573 [TBL] [Abstract][Full Text] [Related]
68. Effectiveness of prokinetic agents against diseases external to the gastrointestinal tract. Hiyama T; Yoshihara M; Tanaka S; Haruma K; Chayama K J Gastroenterol Hepatol; 2009 Apr; 24(4):537-46. PubMed ID: 19220673 [TBL] [Abstract][Full Text] [Related]
69. [Gastrointestinal motility disorders and drugs: opioids, calcium antagonists, nitrates, peptides, prostaglandins and 5-hydroxytryptaminergic drugs (part II)]. Jovanović-Mićić D; Samardzić R; Beleslin B Srp Arh Celok Lek; 1994; 122(3-4):88-92. PubMed ID: 17972818 [TBL] [Abstract][Full Text] [Related]